ATLANTA & BUDAPEST, Hungary--(BUSINESS WIRE)--UPS (NYSE: UPS) today announced it will purchase Hungary-based pharmaceutical logistics company, CEMELOG Zrt, as part of its ongoing global growth and investment strategy. The acquisition further strengthens UPS’s healthcare reach and expertise in Europe, enabling comprehensive, compliant services to customers in the pharmaceutical, biotech and medical device industries across the increasingly important markets of Central and Eastern Europe.
UPS expects to complete the transaction in the second quarter of 2013, subject to customary closing conditions. Per company policy, terms of the deal are not disclosed.
Based outside of Budapest, CEMELOG has offered customers across Central and Eastern Europe tailor-made healthcare logistics solutions for the last fourteen years. Backed by a strong regional network, advanced warehousing management systems, full quality assurance services and an experienced workforce, the company helps healthcare clients maximize supply chain efficiencies, meet regulatory requirements and deliver products reliably and securely. CEMELOG’s customers include some of the most recognized healthcare brands in the world.
“This acquisition is a continuation of our ongoing growth strategy across our business units and allows us to create innovative solutions for our customers that leverage UPS’s global network,” said Scott Davis, UPS Chairman and CEO. “It will position us well to meet the needs of healthcare companies in a key geographic location as they strive to regionalize logistics operations as a way to increase efficiencies.”
“This is a tremendous development for our company,” said Éva Magyari, CEMELOG Chief Executive Officer. “The sale serves the best interests of our employees and customers as it enables us to join a premier brand and global leader in healthcare logistics.”
The acquisition adds three additional facilities of approximately 255,000 square feet (24,000 square meters) of healthcare distribution space to UPS’s current European network. The announcement follows the opening of three new dedicated healthcare facilities across Asia in October 2012 and the expansion of five facilities across North America in early 2013. UPS now operates more than 6.4 million sq. ft. (nearly 595,000 square meters) of dedicated healthcare space in 41 facilities worldwide.
UBS is acting as financial advisor to UPS.
UPS delivers value to healthcare companies through a broad portfolio of specialized freight and small package transportation and distribution services. UPS’s healthcare network offers services such as temperature-sensitive handling, geographic-specific regulatory compliance, monitoring and security, kitting and labeling, as well as order management and accounts receivable. Services across all locations are accessible via one global IT order management platform. UPS helps healthcare manufacturers meet stringent and often complex regulatory requirements, provides flexibility for a changing business environment and reliably serves an increasingly global customer base.
For more information on UPS’s broad healthcare logistics capabilities, visit: www.ups.com/healthcare.
UPS (NYSE:UPS) is a global leader in logistics, offering a broad range of solutions including the transportation of packages and freight, the facilitation of international trade, and the deployment of advanced technology to more efficiently manage the world of business. Headquartered in Atlanta, UPS serves more than 220 countries and territories worldwide. The company can be found on the Web at www.UPS.com and its corporate blog can be found at www.blog.ups.com. To get UPS news direct, visit www.pressroom.ups.com.